MedTrace Logo

Sufentanil Infusion vs Sufentanil Bolus

NCT04226495 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2024-12-11

Study results available
· View outcomes & findings →

Summary

Randomized single blind controlled clinical trial to test the benefit of sufentanil infusion over bolus dosing to reduce time to extubation and reduced length of ICU stay.

Conditions

  • Anesthesia

Interventions

DRUG

Sufentanil Infusion

Intra-operative sufentanil infusion

DRUG

Sufentanil Bolus

Intra-operative sufentanil bolus

Sponsors & Collaborators

  • University of Nebraska

    lead OTHER

Principal Investigators

  • Jeffrey C Songster, MD · University of Nebraska

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-13
Primary Completion
2021-10-28
Completion
2021-10-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04226495 on ClinicalTrials.gov